Image source: © 2025 Krish Capital Pty.Ltd

Highlights

  • Average 1-year price target for BTI stands at USD 40.00 per share
  • Four analysts rate the stock a buy, one maintains a sell recommendation
  • Coverage includes recent ratings from Jefferies, Barclays, and Morgan Stanley

Shares of British American Tobacco p.l.c. (NYSE: BTI) have been given a consensus rating of “Moderate Buy” by five research firms currently tracking the company, according to Marketbeat. The rating distribution reflects one analyst issuing a sell recommendation and four maintaining buy ratings. The average 12-month price target for BTI is USD 40.00, suggesting a moderate upside from its current trading levels.

Several research firms have updated their outlook on BTI in recent months. Jefferies Financial Group began coverage on July 9, assigning a “buy” rating. Barclays reiterated its “overweight” stance in a June 13 note, reflecting expectations of steady demand for the company’s portfolio. Morgan Stanley reaffirmed an “underweight” rating while setting a USD 40.00 price target on August 15, signaling a more cautious view. Wall Street Zen revised its assessment on July 26, moving from a “buy” to a “hold” rating, indicating a neutral stance on the stock’s near-term prospects.

British American Tobacco is a global manufacturer and distributor of tobacco and nicotine products. Its portfolio includes combustible cigarettes, modern oral nicotine products, vapour, and heated tobacco offerings. The company markets products under several well-known brands, including Vuse, glo, Velo, Dunhill, Kent, Lucky Strike, Pall Mall, Rothmans, Camel, and Newport. This diverse brand mix enables the company to serve both traditional and alternative nicotine product markets worldwide.